Annual report pursuant to Section 13 and 15(d)

Cover Page

v3.22.0.1
Cover Page - USD ($)
 12 Months Ended
Dec. 31, 2021
Feb. 18, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-37854    
Entity Registrant Name Ekso Bionics Holdings, Inc.    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 99-0367049    
Entity Address, Address Line One 1414 Harbour Way South    
Entity Address, Address Line Two Suite 1201    
Entity Address, City or Town Richmond    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94804    
City Area Code 510    
Local Phone Number 984-1761    
Title of 12(b) Security Common Stock, $0.001 par value    
Trading Symbol EKSO    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 63,807,354
Entity Common Stock, Shares Outstanding   12,692,919  
Amendment Flag false    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001549084    
Documents Incorporated by Reference
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of the registrant’s Proxy Statement for the 2022 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended December 31, 2021.
    
ICFR Auditor Attestation Flag false